lobbying_activities: 1120473

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1120473	63e89ea4-62c0-403a-aff8-6d0f9e178911	Q2	MCDERMOTT WILL & SCHULTE LLP	24338	ISIS PHARMACEUTICALS	2011	second_quarter	PHA	Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2011-07-19T10:50:42.557000-04:00